Critical assessment of staining properties of a new visualization technology: a novel, rapid and powerful immunohistochemical detection approach

Maximilian Seidl, Brigitte Weinhold, Lars Jacobsen, O. F. Rasmussen, Martin Werner, Konrad AumannHistochemistry 2020 · DOI

TL;DR

This paper introduces and evaluates a new prototype immunohistochemical detection technology (PIDT) that offers significantly faster staining times and improved signal homogeneity compared to a well-established system. PIDT shows particular promise for rapid diagnostics and in settings with limited resources, even performing better with challenging tissue fixation.

What Problem Does This Paper Address?

Immunohistochemistry (IHC) is a cornerstone technique in pathology, crucial for diagnosing diseases and guiding therapies by identifying specific proteins (antigens) within tissue samples. However, traditional IHC methods can be time-consuming, requiring lengthy incubation periods for antibodies. This delay can be a bottleneck, especially in clinical settings where rapid results are critical for patient management. Furthermore, the quality of IHC staining can be highly dependent on tissue preparation, particularly the fixation process, which can vary significantly in routine practice. The authors aim to assess a novel detection technology that promises faster turnaround times and robust performance across various conditions.

Methods

The study critically evaluates a prototype immunohistochemical detection technology (PIDT) developed by Agilent Technologies. PIDT is described as an improved tyramide system that utilizes a two-step DAB (3,3'-diaminobenzidine) deposition process. First, a weak DAB stain acts as an anchor for FITC (fluorescein isothiocyanate) reporters, which are then detected by a second DAB stain with anti-FITC/HRP (horseradish peroxidase). This approach is designed to create crisp, localized stains with strong amplification even with short incubation times.

The researchers compared PIDT against a well-established system, EnVision FLEX, using a panel of 30 different primary antibodies across 11 tumor tissue types. Staining quality was assessed using six parameters: signal distribution, intensity, tissue and slide background, acutance (sharpness), clarity of details, and subcellular morphological details. The study also investigated PIDT's performance under various fixation conditions, including under-fixation, standard fixation, weekend fixation, over-fixation, frozen section conditions, and delayed fixation. A tissue microarray (TMA) was constructed to systematically test these conditions.

Datasets

The study utilized a variety of human tissue samples, including:

  • 11 different tumor tissues for initial antibody screening.
  • Five different tumor types for a more detailed comparison of PIDT and EnVision FLEX with 30 antibodies.
  • Four samples of fresh tonsil tissue, subjected to six different fixation conditions and combined into a tissue microarray (TMA) for robustness testing.
  • Resection specimens from mastectomies and pneumectomies with estrogen receptor- or TTF-1-positive breast and lung adenocarcinomas to evaluate performance in poorly fixed tissues.
  • Bone marrow biopsies infiltrated with follicular lymphoma.

No new benchmark datasets were introduced; the study focused on evaluating existing tissue samples against established IHC protocols.

Key Insights and Ideas

  • Speed is King (and Queen): PIDT dramatically reduces assay run times, primarily due to significantly shorter primary antibody incubation times (often 1-2 minutes compared to much longer times for EnVision FLEX). This is a major advantage for clinical workflows.
  • Uniformity is Underrated: PIDT consistently produces more homogeneous signal distribution across tissue sections, which can lead to more reliable and reproducible quantitative evaluations, especially for computer-assisted image analysis.
  • Robustness in the Face of Imperfection: PIDT demonstrates superior performance in poorly or delayed fixed tissues, a common challenge in routine pathology labs. This resilience makes it a valuable tool when ideal fixation is not achievable.
  • Signal Strength Without Sacrifice: While PIDT often yields higher signal intensity, it does not impair the ability to discern subtle differences in staining intensity between cell types, preserving crucial diagnostic information.

Key Results

  • Run Time Reduction: PIDT achieved an average total staining run time of 58 minutes compared to 111 minutes for EnVision FLEX, a statistically significant difference (p<0.0001). This time saving was particularly pronounced with fewer slides.
  • Signal Homogeneity: PIDT showed statistically significant improvement in signal homogeneity across tissue sections compared to EnVision FLEX.
  • Signal Intensity: PIDT generally provided good to optimal staining intensity, often higher than EnVision FLEX, though this difference was not always statistically significant.
  • Fixation Robustness: While some fixation conditions (e.g., frozen section) resulted in lower scores for both systems, neither system's quality was rendered unacceptable. PIDT showed better signal homogeneity in several suboptimal fixation scenarios, and in one instance, a TTF-1-negative lung adenocarcinoma was weakly positive with PIDT, suggesting enhanced sensitivity.
  • Reproducibility: Staining with PIDT demonstrated high reproducibility, with a low standard deviation (1.7%) in the percentage of Ki-67-positive cells across multiple runs.

Limitations and Future Work

  • Acutance and Morphological Details: While PIDT performed well overall, EnVision FLEX achieved statistically significant higher scores for acutance (sharpness) and morphological details in some evaluations.
  • Bone Marrow Biopsies: While PIDT showed increased signal intensity and homogeneity for CD10 and BCL6 in bone marrow biopsies, the acutance of CD79a staining was slightly impaired.
  • Future Work: The authors suggest that PIDT could be a valuable addition to established detection systems, particularly in settings requiring rapid results or with limited throughput. Further investigation into the underlying mechanisms for PIDT's improved homogeneity and signal intensity is implied. The potential benefits for computer-assisted image processing due to improved signal uniformity are also highlighted.

Summary updated

Abstract

Immunohistochemical staining of tissue sections is a vital technique in pathological diagnostics and theranostics. Several kinds of detection systems are available-each of them with their advantages and disadvantages. Here we present the results of a study assessing a prototype immunohistochemical detection technology (PIDT) for visualization of antigens in tissue sections. Different tumor tissues (n = 11) were stained with selected antibodies (n = 30) and a subset of these under different fixation conditions. The staining properties were assessed according to six staining quality parameters (signal distribution, intensity, tissue and slide background, acutance, clarity of details, and subcellular morphological details), and the results were compared with those of a well-established detection system (EnVision FLEX). Overall, both detection methods revealed good to optimal results regarding the evaluated parameters even under unfavorable fixation conditions. However, with the prototype detection technology a quicker turnaround time was reached primarily due to shorter primary antibody incubation times. Moreover, PIDT-stained tissues showed higher signal intensity and a uniform signal distribution over the tissue slide, still, with well-preserved tissue morphology and without impairing the gradation of staining intensity of different cell types. In particular, the prototype detection technology performed better in poorly or delayed fixed tissue. In situations where rapid and profound results are in demand, and particularly in the context of a small laboratory setting, this prototype detection technology could be a useful addition to the established detection systems.
BibTeX
@inproceedings{seidl2020critical,
  author = {Maximilian Seidl and Brigitte Weinhold and Lars Jacobsen and O. F. Rasmussen and Martin Werner and Konrad Aumann},
  title = {{Critical assessment of staining properties of a new visualization technology: a novel, rapid and powerful immunohistochemical detection approach}},
  booktitle = {Histochemistry},
  year = {2020},
  doi = {10.1007/s00418-020-01906-5},
}
Figure